These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37202930)

  • 21. NATCON 2022 Panel discussion: "TB vaccination - Going Forward".
    Banurekha VV; Padmapriyadarsini C; Bhargava S; Sachdeva K
    Indian J Tuberc; 2023 Jul; 70(3):366-369. PubMed ID: 37562914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Counting the lives saved by DOTS in India: a model-based approach.
    Mandal S; Chadha VK; Laxminarayan R; Arinaminpathy N
    BMC Med; 2017 Mar; 15(1):47. PubMed ID: 28253922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study.
    Harris RC; Sumner T; Knight GM; Evans T; Cardenas V; Chen C; White RG
    Lancet Glob Health; 2019 Feb; 7(2):e209-e218. PubMed ID: 30630775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?
    Martín C
    Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effectiveness of BCG vaccination: the Jordanian experience.
    Batieha A; Abo-Khadhra K; Rawashdah M; Jaddou H; Sheyyab M; Abo-Romman K; Daoud A
    J Trop Pediatr; 1998 Oct; 44(5):288-90. PubMed ID: 9819492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tuberculosis vaccine: A journey from BCG to present.
    Fatima S; Kumari A; Das G; Dwivedi VP
    Life Sci; 2020 Jul; 252():117594. PubMed ID: 32305522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Where do we stand with BCG vaccination programme in Japan?].
    Mori T
    Kekkaku; 2001 Apr; 76(4):385-97. PubMed ID: 11398330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
    Moliva JI; Turner J; Torrelles JB
    Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BCG vaccination in India and tuberculosis in children: newer facets.
    Udani PM
    Indian J Pediatr; 1994; 61(5):451-62. PubMed ID: 7744445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China.
    Weerasuriya CK; Harris RC; McQuaid CF; Bozzani F; Ruan Y; Li R; Li T; Rade K; Rao R; Ginsberg AM; Gomez GB; White RG
    BMC Med; 2021 Feb; 19(1):60. PubMed ID: 33632218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tuberculosis prevalence survey in Japan].
    Shimao T
    Kekkaku; 2009 Nov; 84(11):713-20. PubMed ID: 19999593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection against tuberculosis by Bacillus Calmette-Guérin (BCG) vaccination: A historical perspective.
    Setiabudiawan TP; Reurink RK; Hill PC; Netea MG; van Crevel R; Koeken VACM
    Med; 2022 Jan; 3(1):6-24. PubMed ID: 35590145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of BCG vaccination programmes in children and young adults on the tuberculosis problem.
    Styblo K; Meijer J
    Tubercle; 1976 Mar; 57(1):17-43. PubMed ID: 1085050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
    Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.
    Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group
    Vaccine; 2015 Jun; 33(26):3047-55. PubMed ID: 25882170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCG vaccination strategies against tuberculosis: updates and perspectives.
    Qu M; Zhou X; Li H
    Hum Vaccin Immunother; 2021 Dec; 17(12):5284-5295. PubMed ID: 34856853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is Bacillus Calmette-Guerin revaccination necessary for Japanese children?
    Rahman M; Sekimoto M; Hira K; Koyama H; Imanaka Y; Fukui T
    Prev Med; 2002 Jul; 35(1):70-7. PubMed ID: 12079443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
    Nemes E; Geldenhuys H; Rozot V; Rutkowski KT; Ratangee F; Bilek N; Mabwe S; Makhethe L; Erasmus M; Toefy A; Mulenga H; Hanekom WA; Self SG; Bekker LG; Ryall R; Gurunathan S; DiazGranados CA; Andersen P; Kromann I; Evans T; Ellis RD; Landry B; Hokey DA; Hopkins R; Ginsberg AM; Scriba TJ; Hatherill M;
    N Engl J Med; 2018 Jul; 379(2):138-149. PubMed ID: 29996082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential impact of BCG vaccine supply shortages on global paediatric tuberculosis mortality.
    Harris RC; Dodd PJ; White RG
    BMC Med; 2016 Sep; 14(1):138. PubMed ID: 27633883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in incidence and mortality of tuberculosis in India over past three decades: a joinpoint and age-period-cohort analysis.
    Dhamnetiya D; Patel P; Jha RP; Shri N; Singh M; Bhattacharyya K
    BMC Pulm Med; 2021 Nov; 21(1):375. PubMed ID: 34784911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.